WHO Approval

WHO recommends dengue vaccine developed by Takeda
World+Biz

WHO recommends dengue vaccine developed by Takeda

The WHO recommends that the Qdenga vaccine be introduced to children aged 6-16 years who live in areas "with high dengue disease burden and high transmission intensity"

REUTERS/Denis Balibouse/File Photo
Coronavirus chronicle

WHO, partners seek $23.4 bln for new Covid-19 war chest

Photo: Reuters
World+Biz

Russia sees no hurdles for WHO approval of Sputnik V vaccine

Photo: Courtesy
Covid-19 in Bangladesh

‘Already applied with WHO, now awaiting approval’: Minister on jabbing schoolgoers

Photo: UNB
Coronavirus chronicle

Bharat Biotech submits ‘90% of documents’ for WHO nod

File Photo: A member of the medical staff holds a vial of the Oxford-AstraZeneca COVID-19 vaccine at the Foch hospital in Suresnes, near Paris, France, February 8, 2021. REUTERS/Benoit Tessier
Coronavirus chronicle

WHO approves AstraZeneca/Oxford COVID-19 vaccine for emergency use